Literature DB >> 16908707

Myocardial late gadolinium enhancement is associated with raised serum amino-terminal propeptide of type III collagen concentrations in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha tropomyosin gene: magnetic resonance imaging study.

P Sipola, K Peuhkurinen, K Lauerma, M Husso, P Jääskeläinen, M Laakso, H J Aronen, J Risteli, J Kuusisto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16908707      PMCID： PMC1861167          DOI： 10.1136/hrt.2005.075523

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency.

Authors:  P Uusimaa; J Risteli; M Niemelä; J Lumme; M Ikäheimo; A Jounela; K Peuhkurinen
Journal:  Circulation       Date:  1997-10-21       Impact factor: 29.690

2.  Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.

Authors:  J C Moon; J Mogensen; P M Elliott; G C Smith; A G Elkington; S K Prasad; D J Pennell; W J McKenna
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

3.  The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population.

Authors:  P Jääskeläinen; M Soranta; R Miettinen; L Saarinen; J Pihlajamäki; K Silvennoinen; T Tikanoja; M Laakso; J Kuusisto
Journal:  J Am Coll Cardiol       Date:  1998-11-15       Impact factor: 24.094

4.  Myocardial collagen turnover in hypertrophic cardiomyopathy.

Authors:  Raffaella Lombardi; Sandro Betocchi; Maria Angela Losi; Carlo Gabriele Tocchetti; Mariano Aversa; Marianna Miranda; Gianluigi D'Alessandro; Alessandra Cacace; Quirino Ciampi; Massimo Chiariello
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

5.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.

Authors:  Lubna Choudhury; Heiko Mahrholdt; Anja Wagner; Kelly M Choi; Michael D Elliott; Francis J Klocke; Robert O Bonow; Robert M Judd; Raymond J Kim
Journal:  J Am Coll Cardiol       Date:  2002-12-18       Impact factor: 24.094
  5 in total
  3 in total

1.  Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo.

Authors:  Antonella Moreo; Giuseppe Ambrosio; Benedetta De Chiara; Min Pu; Tam Tran; Francesco Mauri; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2009-09-03       Impact factor: 7.792

2.  Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy.

Authors:  Johanna Kuusisto; Vesa Kärjä; Petri Sipola; Ivana Kholová; Keijo Peuhkurinen; Pertti Jääskeläinen; Anita Naukkarinen; Seppo Ylä-Herttuala; Kari Punnonen; Markku Laakso
Journal:  Heart       Date:  2012-03-24       Impact factor: 5.994

3.  Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy.

Authors:  Pertti Jääskeläinen; Jagadish Vangipurapu; Joose Raivo; Teemu Kuulasmaa; Tiina Heliö; Katriina Aalto-Setälä; Maija Kaartinen; Erkki Ilveskoski; Sari Vanninen; Liisa Hämäläinen; John Melin; Jorma Kokkonen; Markku S Nieminen; Markku Laakso; Johanna Kuusisto
Journal:  ESC Heart Fail       Date:  2019-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.